142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)
Titel:
142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)
Auteur:
Faivre-Finn, C. Snee, M. Ashcroft, L. Appel, W. Barlesi, F. Bhatnagar, A. Bezjak, A. Cardenal, F. Fournel, P. Harden, S. Le Pechoux, C. McMenemin, R. Mohammed, N. O'Brien, M. Pantarotto, J. Surmont, V. Van Meerbeeck, J. Woll, P. Lorigan, P. Blackhall, F.